SARS CoV 2 News and Research

RSS

Study reveals early death predictors in COVID-19 patients with cardiac injury

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The activation of immune and thrombotic biomarkers at admission, and their ability to predict cardiac injury and mortality patterns in COVID-19, remains unclear.

26 Feb 2024

Study reveals how long COVID can affect brain function through vascular disruption

The neurological response to coronavirus disease 2019 (COVID-19) may be due to brain-brain barrier (BBB) disruption.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Identifying antiviral protein IFN-γ as a potential biomarker for Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

24 Feb 2024

Gut microbial metabolite plays a role in exacerbating thrombosis

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis -- the formation of blood clots – researchers report February 23rd in the journal Cell Metabolism.

23 Feb 2024

Yale School of Medicine secures $575,000 grant for Long COVID research

Yale School of Medicine and its Center for Infection & Immunity (CII) are receiving a $575,000 grant from PolyBio Research Foundation to fund Long COVID research.

23 Feb 2024

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

23 Feb 2024

Females' immune system edges out males but at a cost of higher autoimmune risk

A review article highlights how two X chromosomes in females influence immune system composition and function, leading to faster infection clearance and stronger vaccination responses but also a higher risk of autoimmune diseases.

22 Feb 2024

Elevated IFN-γ levels linked to long COVID, study finds

Researchers find elevated IFN-γ levels in long COVID patients, with symptom improvement correlating with decreased IFN-γ, suggesting it as a potential biomarker and target for therapeutic intervention.

22 Feb 2024

Persistent COVID-19 could drive virus evolution, new study suggests

Study reveals the prevalence of persistent SARS-CoV-2 infection in the UK, showing its potential role in viral evolution and the emergence of new variants, with implications for long-COVID and public health strategies.

22 Feb 2024

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

21 Feb 2024

Study highlights an immunological mechanism underlying Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression.

21 Feb 2024

Study reveals high prevalence of persistent COVID-19 infections in general population

A new study led by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more.

21 Feb 2024

COVID-19 linked to higher fatigue rates, says study

A study by the CDC and Washington University found COVID-19 significantly increases the risk of developing fatigue and chronic fatigue, with higher incidence rates compared to non-COVID-19 controls.

19 Feb 2024

Survey of US adults reveals common cognitive symptoms in post-COVID-19 patients, linked to impaired daily functioning and depression

Scientists examined how prevalent self-reported cognitive symptoms were in individuals with post-COVID-19 condition as compared to individuals who had prior severe SARS-CoV-2 infections but had not developed post-COVID-19 condition.

19 Feb 2024

Study reveals seasonal MERS-CoV peaks in Kenyan camels and potential human transmission

Researchers found biphasic peaks of MERS-CoV in dromedaries in Kenya, with evidence of serologic exposure among slaughterhouse workers, highlighting potential human transmission risks.

18 Feb 2024

Wastewater clues could revolutionize Alzheimer's detection

Review explores the potential of wastewater-based epidemiology (WBE) for diagnosing Alzheimer's disease (AD) through biomarkers in biofluids, offering a non-invasive, cost-effective approach to early detection and large-scale monitoring.

18 Feb 2024

New study pinpoints key markers for Long COVID diagnosis

Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential diagnostic approaches.

18 Feb 2024

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

A new preprint reports significantly associated findings that may help predict severe long COVID and understand what causes it.

16 Feb 2024

COVID-19 impacts the brain through body inflammation, research finds

Scientists still are not sure how neurological symptoms arise in COVID-19. Is it because SARS-CoV-2 infects the brain? Or are these symptoms the result of inflammation in the rest of the body?

16 Feb 2024